Cargando…

Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds

Many naturally occurring substances, traditionally used in popular medicines around the world, contain the coumarin moiety. Coumarin represents a privileged scaffold for medicinal chemists, because of its peculiar physicochemical features, and the versatile and easy synthetic transformation into a l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefanachi, Angela, Leonetti, Francesco, Pisani, Leonardo, Catto, Marco, Carotti, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017103/ https://www.ncbi.nlm.nih.gov/pubmed/29382051 http://dx.doi.org/10.3390/molecules23020250

Ejemplares similares

A twenty-year journey exploring coumarin-based derivatives as bioactive molecules
por: Pisani, Leonardo, et al.
Publicado: (2022)

Editorial: Coumarins: New synthetic approaches and new pharmacological applications
por: Stefanachi, Angela, et al.
Publicado: (2023)

Insights into the Complex Formed by Matrix Metalloproteinase-2 and Alloxan Inhibitors: Molecular Dynamics Simulations and Free Energy Calculations
por: Giangreco, Ilenia, et al.
Publicado: (2011)

Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties
por: Kallitsakis, Michael G., et al.
Publicado: (2017)

Dual Reversible Coumarin Inhibitors Mutually Bound to Monoamine Oxidase B and Acetylcholinesterase Crystal Structures
por: Ekström, Fredrik, et al.
Publicado: (2022)

An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities
por: Annunziata, Francesca, et al.
Publicado: (2020)

Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry
por: Barresi, Elisabetta, et al.
Publicado: (2023)

Daphnetin: A bioactive natural coumarin with diverse therapeutic potentials
por: Javed, Maira, et al.
Publicado: (2022)

Privileged heterocycles: bioactivity and synthesis of 1,9-diazaspiro[5.5]undecane-containing compounds
por: Blanco-Ania, Daniel, et al.
Publicado: (2017)

Review on Natural Coumarin Lead Compounds for Their Pharmacological Activity
por: Venugopala, K. N., et al.
Publicado: (2013)

Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
por: Küpeli Akkol, Esra, et al.
Publicado: (2020)

LmrR: A Privileged Scaffold for Artificial Metalloenzymes
por: Roelfes, Gerard
Publicado: (2019)

Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site
por: Dong, Mengqi, et al.
Publicado: (2016)

Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors
por: Melis, Claudia, et al.
Publicado: (2016)

The Fellowship of Privileged Scaffolds—One Structure to Inhibit Them All
por: Skoreński, Marcin, et al.
Publicado: (2021)

Pyrroles as Privileged Scaffolds in the Search for New Potential HIV Inhibitors
por: Bianco, Maria da Conceição Avelino Dias, et al.
Publicado: (2021)

An overview of metal-free synthetic routes to isoxazoles: the privileged scaffold
por: Das, Soumyadip, et al.
Publicado: (2021)

Coumarins, Xanthones and Related Compounds
por: Richomme, Pascal
Publicado: (2016)

Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs
por: Nizi, Maria Giulia, et al.
Publicado: (2023)

Flavonoids and related privileged scaffolds as potential urease inhibitors: a review
por: Al-Rooqi, Munirah M., et al.
Publicado: (2023)

Synthesis, characterization and biological investigations of potentially bioactive heterocyclic compounds containing 4-hydroxy coumarin
por: Nagaraja, O., et al.
Publicado: (2020)

Synthesis and Chemical Properties of 3-Phosphono-coumarins and 1,2-Benzoxaphosphorins as Precursors for Bioactive Compounds
por: Koleva, Ana I., et al.
Publicado: (2019)

Priviléges /
por: Beauvoir, Simone de, 1908-1986
Publicado: (1955)

Privileges
por: Jagannathan, Mukund
Publicado: (2016)

A Review of Coumarins and Coumarin-Related Compounds for Their Potential Antidiabetic Effect
por: Ranđelović, Sara, et al.
Publicado: (2021)

Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to
por: Carofiglio, Francesca, et al.
Publicado: (2020)

Green Synthesis of Privileged Benzimidazole Scaffolds Using Active Deep Eutectic Solvent
por: Di Gioia, Maria Luisa, et al.
Publicado: (2019)

3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade
por: Matos, Maria J., et al.
Publicado: (2021)

The privileged immunity of immune privileged organs: the case of the eye
por: Benhar, Inbal, et al.
Publicado: (2012)

Immune Privilege: Keeping an Eye on Natural Killer T Cells
por: Hong, Seokmann, et al.
Publicado: (1999)

Natural and Synthetic Oligoarylamides: Privileged Structures for Medical Applications
por: Seedorf, Tim, et al.
Publicado: (2021)

Searching for Multi-Targeting Neurotherapeutics against Alzheimer’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif
por: Pisani, Leonardo, et al.
Publicado: (2016)

Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds
por: Li Petri, Giovanna, et al.
Publicado: (2021)

Bioactive Natural Matrices and Compounds
por: Ferreira, Isabel C. F. R., et al.
Publicado: (2014)

The Privilege of Suffering
Publicado: (1886)

The Privilege of Suffering
Publicado: (1886)

Ransomware and Privileges
por: Haber, Morey J.
Publicado: (2020)

Privileged Communications
Publicado: (1852)

Retrieval of High Added Value Natural Bioactive Coumarins from Mandarin Juice-Making Industrial Byproduct
por: Myrtsi, Eleni D., et al.
Publicado: (2021)

Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV Agents
por: Cichero, Elena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ba5u0b2rie021bs3894jc85pia